Study of serum prolactin level in women with Hyperthyroidism
Phase 2
- Conditions
- hyperthyroidism.Hyperthyroidism NOS
- Registration Number
- IRCT201207191774N4
- Lead Sponsor
- Vice chancellor for Research and Technology of kerman University of Medical Sciences, Physiology res
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 160
Inclusion Criteria
Women with hyperthyroidism; Age between 15 to 50 years
Exclusion criteria :
use of drugs which increase prolactine level: dopamine receptor blocker including phenotiazine,chlorpromazin,perfenazine,butirofenon,haloperidole,thioxantine,metocloperamide ; dopamin synthesis inhibitor(etc. methyldopa) ;cathecolamin releasing agent: reserpin; Opiates ;H2 blockers including cimetidin,ranitidin; Imipramin,Amitriptylin; serotonin intake inhibitor:Fluoxetin; Calcium channel blockers:Verapamil; hormones: Estrogens;Antiandrogens,TRH; Others:pregnancy,lactation,liver disease,chronic kidney disease.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum prolactine level. Timepoint: Pre-treatment; post-treatment. Method of measurement: ICMA.
- Secondary Outcome Measures
Name Time Method